Anderson, J. M., Stevenson, B. R., Jesaitis, L. A., Goodenough D. A. and Mooseker, M. S (1988). Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J. Cell Biol 106, 1141-1149.[Abstract/Free Full Text]
Bargmann, C. I., Hung, M.-C. and Weinberg. R. A (1986). The neu oncogene encodes an epidermal growth factor related protein. Nature 319, 226-230.[Medline]
Bargmann, C. I., Hung, M.-C. and Weinberg, R. A (1986). Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45, 649-657.[Medline]
Bargmann, C. I. and Weinberg, R. A (1988). Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J 7, 2043-2052.[Medline]
Berger, M. S., Locher, G. W., Saurer, S., Gullick, W. J., Waterfield, M. D., Groner, B. and Hynes, N. E (1988). C-erbB-2 gene amplification and protein expression in human breast carcinoma correlate with nodal status and nuclear grading. Cancer Res 48, 1238-1243.[Abstract/Free Full Text]
Blochiger, K. and Diggelmann, H (1984). Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol. Cell. Biol 4, 2929-2931.[Abstract/Free Full Text]
Bishop, J. M (1991). Molecular Themes in Oncogenesis. Cell 64, 235-248.[Medline]
Bradford, M. M (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem 72, 248-254.[Medline]
Buck, C. A. and Horwitz, A. F (1987). Cell surface receptors for extracellular matrix molecules. Annu. Rev. Cell Biol 3, 179-205.
Cohen, J. A., Weiner, D. B., More, K. F., Kokai, Y., Williams, W. V., Maguire-Jr, H. C., LiVolsi V. A. and Greene. M. I (1989). Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185 neu ) in normal and transformed epithelial tissues of the digestive tract. Oncogene 4, 81-88.[Medline]
Di Fiore, P. P., Pierce, J. H., Kraus, M. H. Segatto, O. King, C. R. and Aaronson, S. A (1987). ErbB-2 is a potent oncogene when overexpressed in NIH 3T3 cells. Science 237, 178-182.[Abstract/Free Full Text]
Durban, E. M., Medina, D. and Butel, J. S (1985). Comparative analysis of casein synthesis during mammary cell differentiation in collagen and mammary gland development in vivo. Dev. Biol 109, 288-298.[Medline]
Entwistle, A., Hoffmann, H. Noble, M. and Stroobant, P (1990). Measurement of the diffusion time of small molecules into cell aggregates using confocal microscopy. Trans. Microsc. Soc 1, 361-364.
Entwistle, A. and Noble, M (1990). The semi-quantitative measurement of nuclear SV40 large T antigen amploying confocal microscopy. Trans. Microsc. Soc 1, 405-408.
Entwistle, A. and Noble, M (1992). The use of polarisation analysis in the quantification of fluorescent emission: general principles. J. Microsc 165, 331-346.
Entwistle, A. and Noble, M (1992). The use of Lucifer yellow, bodipy, FITC, TRITC, RITC and Texas Red for dual immunofluorescence visualised with a laser scanning confocal microscope. J. Microsc 168, 219-238.
Falls, D. L., Rosen, K. M., Corfas, G., Lane, W. S. and D. Fischbach, G (1993). ARIA, a protein that stimulates acetylcholine receptors synthesis is a member of the neu ligand family. Cell 72, 801-815.[Medline]
Gullick, W. J., Berger, M. S., Bennett, P. L. P., Rothbard, J. B. and Waterfield, M. D (1987). Expression of the c-erbB2 protein in normal and transformed cells. Int. J. Cancer 40, 246-254.[Medline]
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. K., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., Shepard, H. M., Kuang, W-J., Wood, W. I., Goeddel, D. V. and Vandlen, R. L (1992). Identification of heregulin, a specific activator of p185erbB2. Science 256, 1205-1210.[Abstract/Free Full Text]
Hudziak, R. M., Lewis, G. D., Shalaby, M. R., Eessalu, T. E., Aggarwal, B. B., Ullrich, A. and Shepard, H. M (1987). Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumour necrosis factorin NIH 3T3 cells. Proc. Nat. Acad. Sci. USA 84, 7159-7163.[Abstract/Free Full Text]
Hung, M.-C., Schechter, A. L., Chevray, P.-Y. M., Stern, D. F. and Weinberg, R. A (1986). Molecular cloning of the neu gene: Absence of gross structural alteration in oncogenic alleles. Proc. Nat. Acad. Sci. USA 83, 261-264.[Abstract/Free Full Text]
Johnson, G. D., Davidson, R. S., McNamee, K. C., Russell, G., Goodwin, D. and Holborow, E. J (1982). Fading of immunofluorescence during microscopy: A study of the phenomenon and its remedy. J. Immun. Meth 55, 231-242.[Medline]
Kokai, Y., Cohen, J. A., Drebin, J. A. and Greene, M. I (1987). Stage-and tissue-specific expression of the neu oncogene in rat development. Proc. Nat. Acad. Sci. USA 84, 8498-8501.[Abstract/Free Full Text]
Kokai, Y., Meyers, J. N., Wada, T., Brown, V. I., LeVea, C. M., Davis, J. G., Dobashi, K. and Greene, M. I (1989). Synergistic interactions of p185 c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58, 287-292.[Medline]
Kraus, M. H., Popescu, M. C., Amsbaugh, S. C. and King, C. R (1987). Overexpression of the EGF receptor related proto-oncogene erbB-2 in mammary tumour cell lines by different molecular mechanisms. EMBO J 6, 605-610.[Medline]
Lathe, R., Vilotte, J. L. and Clark, A. J (1987). Plasmid and bacteriophage vectors for excision of intact inserts. Gene 57, 193-201.[Medline]
Laemmli, U. K (1970). Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227, 680-685.[Medline]
Lepp\212, S., H\212rk\232nen, P. and Jalkanen, M (1991). Steroid-inducedepithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumour cells. Cell Regul 2, 1-11.[Medline]
Li, M. L., Aggeler, J., Farson, D. A., Hatier, C., Hassell, J. and Bissell, M. J (1987). Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Nat. Acad. Sci. USA 84, 136-140.[Abstract/Free Full Text]
Macpherson, I. and Montagnier, L (1964). Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23, 291-294.[Medline]
Marchionni, M. A., Goodearl, A. D. J., Chen, M. S., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D., Lynch, C., Baldassare, M., Hiles, I., Davis, J. B., Hsuan, J. J., Totty, N. F., Otsu, M., McBurney, R. N., Waterfield, M. D., Stroobant, P. and Gwynne, D (1993). Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362, 312-318.[Medline]
McGeady, M. L., Kerby, S., Shankar, V., Ciardiello, F., Salomon, D. and Seidman, M (1989). Infection with TGF-retroviral vector transforms normal mouse mammary epithelial cell but not normal rat fibroblasts. Oncogene 4, 1375-1382.[Medline]
Parry, G., Cullen, B., Kaetzel, C. S., Kramer, R. and Moss, L (1987). Regulation of differentiation and polarized secretion in mammary epithelial cells maintained in culture: Extracellular matrix and membrane polarity influences. J. Cell. Biol 105, 2043-2051.[Abstract/Free Full Text]
Reichmann, E., Ball, R., Groner, B. and Friis, R. R (1989). New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiated functionally. J. Cell Biol 108, 1127-1139.[Abstract/Free Full Text]
Reichmann, E., Schwarz, H., Deiner, E. M., Leitner, I., Eilers, M., Berger, J., Busslinger, M. and Beug, H (1992). Activation of an inducible c-FosER Fusion Protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71, 1-20.[Medline]
Rijsewijk, F., van Deemter, L., Wagenaar, E., Sonnenberg, A. and Nusse, R (1987). Transfection of the int-1 mammary oncogene in cuboidal RAC mammary cell line results in morphological transformation an tumour igenicity. EMBO J 6, 127-131.[Medline]
Schechter, A. L., Hung, M.-C., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I. and Weinberg, R. A (1984). The neu oncogene: an erb-B-related gene encoding a 185, 000-Mr tumour antigen. Nature 312, 513-516.[Medline]
Simons, K. and Fuller, S. D (1985). Cell surface polarity in epithelia. Annu. Rev. Cell. Biol 1, 243-288.
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A. and McGuire, W. L (1987). Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182.[Abstract/Free Full Text]
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A. and Press, M. F (1989). Studies on HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712.[Abstract/Free Full Text]
Southern, P. J. and Berg, P (1982). Transformation of mammalian cells to antibiotic resistance with a bacterial gene under the control of the SV40 early region promoter. J. Mol. Appl. Genet 1, 327-341.[Medline]
Stern, D. F., Heffernan, P. A. and Weinberg, R. A (1986). p185, a product of the neu proto-oncogene, is a receptor-like protein associated with protein-tyrosine kinase activity. Mol. Cell. Biol 6, 1329-1740.[Abstract/Free Full Text]
Stern, D. F., Kamps, M. P. and Cao, H (1988). Oncogenic activation of p185 neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol 8, 3969-3973.[Abstract/Free Full Text]
Strange, R., Feng, L. Friis, R. R. Reichmann, E. Haenni, B. and Burri, P. H (1991). Mammary epithelial differentiation in vitro : Minimum requirements for a functional response to hormonal stimulation. Cell Growth Differ 2, 549-559.[Abstract]
Streuli, C. H. and Bissel, M. J (1990). Expression of extracellular matrix components is regulated by substratum. J. Cell Biol 110, 1405-1415.[Abstract/Free Full Text]
Streuli, C. H., Bailey, N. and M. J. Bissel (1991). Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J. Cell Biol 115, 1383-1395.[Abstract/Free Full Text]
Van de Vijver, M., van de Bersselaar, R., Devilee, P., Cornelisse, C., Peterse, J. and Nusse, R (1987). Amplification of the neu (c-erbB-2) oncogene in human mammary tumours is relatively frequent and is often accompanied by amplification of the linked c-erb-A oncogene. Mol. Cell. Biol 7, 2019-2023.[Abstract/Free Full Text]
Varley J. M., Swallow, J. E., Brammer, W. J., Whittaker, J. L. and Walker, R. A (1987). Alterations to either c-erbB-2(neu) or c-myc proto-oncogene inbreast carcinomas correlate with poor short-term prognosis. Oncogene 1, 423-430.[Medline]
Weiner, D. B., Liu, J., Cohen, J. A., Williams, W. V. and Greene, M. I (1989). A point mutation in the neu oncogene mimic ligands induction of receptor activation. Nature 339, 230-234.[Medline]
Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., Koski, R. A. Lu, H. S. and Yarden, Y (1992). Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69, 559-572.[Medline]
Wigler, M., Silverstein, S., Lee, L. S., Pellicer, A., Cheng, Y. C. and Axel, R (1977). Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11, 223-232.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
